G4ID was born from Philips Medical Systems Technology
Leveraging whole genome sequencing platform from Oncology Informatics Business and real-time enterprise HIT interfacing from Connected Care Business
2017
Organic Innovation running at Royal Dutch Philips (Medical Systems)
Developed and delivered new-to-world technology, and deployed at research sites.
2018
Technology Validation
Secured peer reviewed evidence confirming clinical benefit and validating technical approach.
2019
Release to Market
Released the platform under the Philips Medical Quality Management System, ensuring the highest quality commercial standards.
2019
Protect IP and Know-How
Built strong IP protection that includes over 30 patent families, trade secret, and copyright.
2021
Spin Out
Identified Molecular Epidemiology spin out leadership team, spin out efforts initiated
2022
Genomics for Infectious Disease born
Secured license from Philips and created G4ID as LLC.
The G4ID Team
Brian Gross, M.Sc., BSEE, SMIEEE, RRT
Founder and CEO
- Fellow Scientist with Philips for over 30 years
- Business leader with customer and technical networks
Inventor with 30+ patent families in use today
- Involved with over 25 successful product launches at Philips
- Originator of AIME technology as a commercial platform
Contact us
Please share your contact details and our team will respond as soon as possible